OMEGA DIAGNOST.GR. LS-04
Cambridge Nutritional Sciences plc, together with its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the FoodPrint brand. It also provides clinical analysis to the general public, clinics, and heal… Read more
OMEGA DIAGNOST.GR. LS-04 (RVKA) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, OMEGA DIAGNOST.GR. LS-04 (RVKA) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
OMEGA DIAGNOST.GR. LS-04 - Net Assets Trend (None–None)
This chart illustrates how OMEGA DIAGNOST.GR. LS-04's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for OMEGA DIAGNOST.GR. LS-04 (None–None)
The table below shows the annual net assets of OMEGA DIAGNOST.GR. LS-04 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to OMEGA DIAGNOST.GR. LS-04's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
OMEGA DIAGNOST.GR. LS-04 Competitors by Market Cap
The table below lists competitors of OMEGA DIAGNOST.GR. LS-04 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Champion Pacific Indonesia Tbk
JK:IGAR
|
$3.09 Million |
|
Rolta India Limited
NSE:ROLTA
|
$3.10 Million |
|
Kordellos Ch. Bros S.A
AT:KORDE
|
$3.10 Million |
|
Rectitude Holdings Ltd Ordinary Shares
NASDAQ:RECT
|
$3.10 Million |
|
InCity Immobilien AG
XETRA:IC8
|
$3.09 Million |
|
Val-d'Or Mining Corporation
PINK:VDOMF
|
$3.09 Million |
|
PT Graha Mitra Asia Tbk
JK:RELF
|
$3.09 Million |
|
Mandarin Hotel Public Company Limited
BK:MANRIN
|
$3.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in OMEGA DIAGNOST.GR. LS-04's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares OMEGA DIAGNOST.GR. LS-04's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently OMEGA DIAGNOST.GR. LS-04 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares OMEGA DIAGNOST.GR. LS-04's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $9,394,036,854
- Average return on equity (ROE) among peers: 4.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| OMEGA DIAGNOST.GR. LS-04 (RVKA) | €- | N/A | N/A | $3.09 Million |
| Modern Dental Group Limited (1MD) | $2.36 Billion | 15.30% | 0.55x | $193.75 Million |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $482.88 Million |
| Alcon Inc. (2U3) | $19.26 Billion | 1.95% | 0.45x | $33.73 Billion |
| Shofu Inc. (69W) | $35.51 Billion | 8.83% | 0.23x | $215.32 Million |
| 7VG (7VG) | $176.36 Million | 14.92% | 1.12x | $684.88 Million |
| Bio-gate AG (BIG1) | $4.25 Million | -42.46% | 0.46x | $2.79 Million |
| Paul Hartmann AG (PHH2) | $690.37 Million | 10.65% | 0.81x | $776.29 Million |
| Sartorius AG VZO O.N. (SRT) | $497.08 Million | 9.76% | 1.56x | $6.78 Billion |
| Shandong Weigao Group Medical Polymer Company Limited (UK2) | $25.34 Billion | 8.16% | 0.37x | $1.36 Billion |